STVN logo

STVN
Stevanato Group Spa

185
Mkt Cap
$4.92B
Volume
218,678.00
52W High
$28.00
52W Low
$12.89
PE Ratio
29.98
STVN Fundamentals
Price
$18.01
Prev Close
$17.85
Open
$17.84
50D MA
$15.82
Beta
0.86
Avg. Volume
621,355.59
EPS (Annual)
$0.5782
P/B
2.79
$5,889.31
Loading...
Loading...
News
all
press releases
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
Stevanato (STVN) delivered earnings and revenue surprises of +6.56% and +2.32%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
More News
News Placeholder
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...
News Placeholder
Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates
Madrigal (MDGL) delivered earnings and revenue surprises of +9.97% and +3.38%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Stevanato Group to Participate in Three Upcoming Investor Conferences
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences: Tuesday, May 12, at 8:00...
News Placeholder
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
News Placeholder
Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of "Hold" by Brokerages
Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have been assigned an average rating of "Hold" from the five ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a...
News Placeholder
Jennison Associates LLC Buys 213,602 Shares of Stevanato Group S.p.A. $STVN
Jennison Associates LLC grew its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 13.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,772,896 shares of the company's stock after acquiring an...
News Placeholder
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
News Placeholder
Stevanato Group (NYSE:STVN) Sees Unusually-High Trading Volume - Should You Buy?
Stevanato Group (NYSE:STVN) Sees Unusually-High Trading Volume - Should You Buy...
News Placeholder
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available